About
FEMSelect develops EnPlace, an FDA-cleared, minimally invasive medical device and procedure for same-day treatment of pelvic organ prolapse, aimed at restoring pelvic support without an overnight hospital stay.
Explore FEMSelect's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.